DEA schedule
Is dextroamphetamine and amphetamine a controlled substance?
Federal schedule for dextroamphetamine and amphetamine from the FDA NDC directory, checked against the DEA controlled substances list.
Source: FDA NDC Directory file dated 2026-10-22. Publisher page
Yes. Dextroamphetamine and amphetamine is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Run it in Rivvi
Which 2027 plans near you dropped or restricted dextroamphetamine and amphetamine?
Tier changes and new prior auth, step therapy or quantity limits, plan by plan.
Free to start. Opens Rivvi, the AI workspace for healthcare teams.
Schedule check
| Source | What it lists |
|---|---|
| FDA NDC directory | 220 prescription listings from 25 labelers, all Schedule II |
| DEA controlled substances list | Amphetamine: Schedule II |
DEA list entry
| Substance | DEA code | Schedule | Narcotic | Other names | Match |
|---|---|---|---|---|---|
| Amphetamine | 1100 | II | No | Dexedrine; Adderall; Obetrol | Isomer or salt of the listed substance (21 CFR 1308) |
| Amphetamine | 1100 | II | No | Dexedrine; Adderall; Obetrol | Listed by name |
Dextroamphetamine and Amphetamine NDC listings
| NDC | Product | Form | Strength | Labeler | DEA schedule |
|---|---|---|---|---|---|
| 54092-381 | Adderall XR | capsule, extended release | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-383 | Adderall XR | capsule, extended release | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-385 | Adderall XR | capsule, extended release | 3.75 mg/1; 3.75 mg/1; 3.75 mg/1; 3.75 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-387 | Adderall XR | capsule, extended release | 5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-389 | Adderall XR | capsule, extended release | 6.25 mg/1; 6.25 mg/1; 6.25 mg/1; 6.25 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-391 | Adderall XR | capsule, extended release | 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-477 | MYDAYIS | capsule, extended release | 12.5 mg/1; 12.5 mg/1; 12.5 mg/1; 12.5 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-468 | MYDAYIS | capsule, extended release | 3.125 mg/1; 3.125 mg/1; 3.125 mg/1; 3.125 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-471 | MYDAYIS | capsule, extended release | 6.25 mg/1; 6.25 mg/1; 6.25 mg/1; 6.25 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 54092-474 | MYDAYIS | capsule, extended release | 9.375 mg/1; 9.375 mg/1; 9.375 mg/1; 9.375 mg/1 | Takeda Pharmaceuticals America, Inc. | CII |
| 57844-105 | Adderall | tablet | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 57844-117 | Adderall | tablet | 1.875 mg/1; 1.875 mg/1; 1.875 mg/1; 1.875 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 57844-110 | Adderall | tablet | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 57844-112 | Adderall | tablet | 3.125 mg/1; 3.125 mg/1; 3.125 mg/1; 3.125 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 57844-115 | Adderall | tablet | 3.75 mg/1; 3.75 mg/1; 3.75 mg/1; 3.75 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 57844-120 | Adderall | tablet | 5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 57844-130 | Adderall | tablet | 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg/1 | Teva Pharmaceuticals USA, Inc. | CII |
| 0406-8891 | Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | SpecGx LLC | CII |
| 0406-8884 | Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet | 1.875 mg/1; 1.875 mg/1; 1.875 mg/1; 1.875 mg/1 | SpecGx LLC | CII |
| 0406-8892 | Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | SpecGx LLC | CII |
| 0406-8885 | Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet | 3.75 mg/1; 3.75 mg/1; 3.75 mg/1; 3.75 mg/1 | SpecGx LLC | CII |
| 0406-8893 | Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet | 5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1 | SpecGx LLC | CII |
| 0406-8894 | Dextroamphetamine Saccharate and Amphetamine Aspartate and Dextroamphetamine Sulfate and Amphetamine Sulfate | tablet | 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg/1 | SpecGx LLC | CII |
| 0115-1486 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0115-1487 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0115-1488 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule | 3.75 mg/1; 3.75 mg/1; 3.75 mg/1; 3.75 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0115-1489 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule | 5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0115-1490 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule | 6.25 mg/1; 6.25 mg/1; 6.25 mg/1; 6.25 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0115-1491 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule | 7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg/1 | Amneal Pharmaceuticals of New York LLC | CII |
| 0527-0790 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | Lannett Company, Inc. | CII |
| 31722-185 | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | capsule, extended release | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | Camber Pharmaceuticals, Inc. | CII |
| 51407-557 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | Golden State Medical Supply, Inc. | CII |
| 63629-1978 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | Bryant Ranch Prepack | CII |
| 70010-029 | dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate | capsule, extended release | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | Granules Pharmaceuticals Inc. | CII |
| 72162-1377 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1 | Bryant Ranch Prepack | CII |
| 0527-0791 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | Lannett Company, Inc. | CII |
| 31722-186 | DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE MONOHYDRATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE | capsule, extended release | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | Camber Pharmaceuticals, Inc. | CII |
| 51407-558 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | Golden State Medical Supply, Inc. | CII |
| 63629-1973 | Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate | capsule, extended release | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | Bryant Ranch Prepack | CII |
| 70010-030 | dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate | capsule, extended release | 2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1 | Granules Pharmaceuticals Inc. | CII |
Showing 40 of 220 listings.
Questions
Is dextroamphetamine and amphetamine a controlled substance?
Yes. Dextroamphetamine and amphetamine is a Schedule II controlled substance under the federal Controlled Substances Act. Matching DEA list entry: Amphetamine (Schedule II).
Is dextroamphetamine and amphetamine a narcotic?
No. The DEA list does not mark dextroamphetamine and amphetamine as a narcotic (NARC = N) and places it in Schedule II. Its FDA established pharmacologic class is Central Nervous System Stimulant.
What schedule is dextroamphetamine and amphetamine?
Dextroamphetamine and amphetamine is Schedule II in the FDA NDC directory, which matches the DEA controlled substances list.
Does this page cover state schedules?
No. This page reports the federal schedule only. Some states schedule drugs on their own; check your state board of pharmacy.
More on Dextroamphetamine and Amphetamine
- What is Dextroamphetamine and Amphetamine used for?FDA label uses
- Generic for Adderall XRFDA Orange Book
- Generic for MydayisFDA Orange Book
- Generic for AdderallFDA Orange Book
- What is Adderall used for?FDA label uses
- Is Adderall a controlled substance?Schedule II
- What is Mydayis used for?FDA label uses
- Is Mydayis a controlled substance?Schedule II
- Central Nervous System Stimulants listFDA drug class
- NDC 54092-381Dextroamphetamine and Amphetamine NDC record
- NDC 54092-383Dextroamphetamine and Amphetamine NDC record
- NDC 54092-385Dextroamphetamine and Amphetamine NDC record
- Schedule II drugs listDEA schedule